| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 56,370 | 59,281 | 61,032 | 64,133 | | Cost of Revenue | 39,422 | 39,598 | 41,899 | 48,365 | | | Gross Profit | 16,948 | 19,683 | 19,133 | 15,768 | | | Operating Expenses | | Research Development | 2,026 | 2,161 | 1,737 | 1,645 | | Selling General and Administrative | 9,295 | 8,546 | 9,048 | 9,010 | | Non Recurring |
-
|
-
|
-
| 3,333 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,627 | 8,976 | 8,348 | 1,780 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 31 | 41 | 67 | 507 | | Earnings Before Interest And Taxes | 2,248 | 9,017 | 8,415 | 2,287 | | Interest Expense | (2,299) | 1,142 | 1,157 | 2,168 | | Income Before Tax | 4,547 | 7,875 | 7,258 | 119 | | Income Tax Expense | 1,584 | 2,416 | 2,520 | 1,069 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,963 | 5,459 | 4,738 | (950) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,963 | 5,459 | 4,738 | (950) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,963 | $5,459 | $4,738 | ($950) |
|
0.51% Nasdaq 
Income Statement
